insulin

Is This a MannKind Killer?
Motley Fool
Tue, 09/3/13 - 09:54 am
MannKind
diabetes
Afrezza
BIOD-123
insulin
Biodel
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Mon, 08/19/13 - 09:43 am
MannKind
FDA
Afrezza
diabetes
insulin
inhaled insulin
Eli Lilly
Pfizer
Novo Nordisk
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Bloomberg
Fri, 08/16/13 - 10:42 am
insulin
diabetes
Sanofi
Novo Nordisk
Levemir
Lantus
Victoza
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Yahoo/AP
Wed, 08/14/13 - 09:17 am
insulin
diabetes MannKind
Afrezza
inhaled insulin
The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Sanofi
insulin
Eli Lilly
Novo Nordisk
diabetes
U300
Lantus
LixiLan
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sun, 06/23/13 - 11:30 am
Sanofi
U300
insulin
type 2 diabetes
diabetes
Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:19 am
LY2605541
Eli Lilly
insulin
type 1 diabetes
diabetes
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin
Seeking Alpha
Mon, 05/20/13 - 09:54 am
Oramed Pharmaceuticals
diabetes
insulin
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
Tue, 04/23/13 - 07:54 am
Eli Lily
diabetes
insulin
LY2605541
dulaglutide
LY2963016
empagliflozin
Lilly diabetes drug as good as insulin in study
Reuters
Tue, 04/16/13 - 10:15 am
Eli Lilly
insulin
diabetes
dulaglutide
Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
Yahoo
Tue, 04/2/13 - 09:55 am
Eli Lilly
drug manufacturing
insulin
Novo Nordisk’s Oral Insulin Successfully Completes Early Study
Bloomberg
Wed, 03/20/13 - 11:54 am
insulin
Novo Nordisk
diabetes
Merrion
Novo Nordisk hit by insulin drug doubts, downgrade
Marketwatch
Tue, 03/19/13 - 10:53 am
insulin
Novo Nordisk
Tresiba
Mylan, Biocon help market generic insulin drugs
Yahoo/AP
Thu, 02/14/13 - 10:18 am
Biocon
Mylan
generics
diabetes
insulin
Lantus
Humalog
Novolog
Sanofi advances after FDA delays rival insulin product
The Fly on the Wall
Mon, 02/11/13 - 11:07 am
FDA
insulin
Novo Nordisk
Sanofi
Tresiba
Lantus
Novo Nordisk hit hard as U.S. rebuffs insulin drug
Yahoo/Reuters
Mon, 02/11/13 - 08:15 am
insulin
Novo Nordisk
diabetes
FDA
Tresiba
CeQur lands CE Mark for its PaQ continuous insulin delivery device
Thu, 11/29/12 - 11:24 pm
CeQur
CE Mark
insulin
Biocon, Bristol-Myers in deal for oral insulin drug
Reuters
Fri, 11/16/12 - 10:10 am
Biocon
Bristol-Myers Squibb
insulin
diabetes
IN-105
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Fri, 11/9/12 - 11:07 am
Novo Nordisk
Tresiba
diabetes
degludec
insulin

Pages